Clinical Trials Logo

Medulloblastoma, Childhood clinical trials

View clinical trials related to Medulloblastoma, Childhood.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT01697514 Withdrawn - Rhabdomyosarcoma Clinical Trials

A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma

Start date: July 2013
Phase: Phase 1
Study type: Interventional

The purpose of this study is to find a recommended dose level of LY2940680 that can be safely given to children with medulloblastoma or rhabdomyosarcoma that has returned or doesn't respond to initial treatment. The study will also explore the changes in a cancer marker levels. Finally, the study will help document any antitumor activity.